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erosion. Pathologic diagnosis of Mycobacterium infec-
tion from bony specimens was recorded for 35 (92%) pa-
tients. For 29 (76%), diagnosis was conducted by molecu-
lar study, including 25 (66%) by the national reference 
mycobacterial laboratory. For 4 patients, diagnosis was 
confirmed by culture of M. bovis. Osteomyelitis/osteitis 
for 5 patients was considered BCG related according to 
pathologic diagnosis of Mycobacterium infection, BCG 
vaccination history, and lack of a history of contact with a 
person with tuberculosis.
Thirty-two (84%) children underwent surgery (exci-
sion, debridement, open biopsy), 4 children received ar-
throtomy (3 ankle and knee joint), and 2 children underwent 
only aspiration biopsy. All patients received isoniazid and 
rifampin therapy; 33 patients also received pyrazinamide, 
and 6 received additional ethambutol therapy. Medications 
were adjusted after diagnoses changed from tuberculosis 
to BCG infection. Two patients had major sequelae, both 
involving the thoracic spine and causing severe kyphosis.
Adverse reactions after BCG vaccination depend 
on the BCG dose, vaccine strain, vaccine administration 
method, injection technique, and recipient’s underlying 
immune status (5). The vaccine strain and manufacturing 
process in Taiwan did not change during the study period. 
Findings were not associated with a specific batch of vac-
cine, inoculation age, underlying disease, or Salmonella 
spp. infection. Patients had no common birth place, hospi-
tal, or area of residence. We believe the increased number 
of cases resulted mainly from policy changes and labora-
tory facility improvements.
A surgical approach to obtain a specimen is indicated. 
However, because medical treatment usually yields a good 
outcome (6), extensive debridement should be avoided. 
Although some patients with lower extremity involvement 
initially limped, most were able to walk well later. Vertebral 
involvement is rare. Unlike previously reported cases (7,8), 
both patients reported here who had vertebral involvement 
had sequelae. For young children with suspected vertebral 
tuberculosis but no tuberculosis contact history, a biopsy 
specimen for BCG studies is preferable to spondylectomy. 
Although no definite immunologic deficit was found in 
these BCG osteomyelitis/osteitis patients, 2 other compen-
sated infants with disseminated BCG during the same peri-
od in Taiwan had identified immunodeficiency (9). Studies 
are ongoing by the Taiwan Centers for Disease Control to 
evaluate medical treatment duration, long-term outcomes, 
and more detailed immune genetic tests.
Acknowledgments
We thank the members of the Taiwan Vaccine Injury Compen-
sation Program committee for their evaluation of the relation 
between BCG and possible adverse reactions in the patients of 
this study.
This research is approved and funded by Taiwan Centers for Dis-
ease Control, Ministry of Health and Welfare, Executive Yuan 
(project no. YY101015).
References
  1. Jou R, Huang WL, Su WJ. Tokyo-172 BCG vaccination  
complications, Taiwan. Emerg Infect Dis. 2009;15:1525–6.  
http://dx.doi.org/10.3201/eid1509.081336
  2. Chan PC, Huang WL, Wang KF, Ma CY, Lu BY, Lin FT, et al.  
The active surveillance of BCG-related adverse events. Taiwan 
Epidemiology Bulletin. 2012;28:13–21.
  3. Koyama A, Toida I, Nakata S. Osteitis as a complication of BCG 
vaccination [in Japanese]. Kekkaku. 2009;84:125–32.
  4. Böttiger M, Romanus V, de Verdier C, Boman G. Osteitis and 
other complications caused by generalized BCG-itis. Experiences 
in Sweden. Acta Paediatr Scand. 1982;71:471–8. http://dx.doi.
org/10.1111/j.1651-2227.1982.tb09454.x
  5. Lotte A, Wasz-Höckert O, Poisson N, Dumitrescu N, Verron M, 
Couvet E. A bibliography of the complications of BCG vaccination. 
A comprehensive list of the world literature since the introduction 
of BCG up to July 1982, supplemented by over 100 personal  
communications. Adv Tuberc Res. 1984;21:194–245.
  6. Kröger L, Korppi M, Brander E, Kröger H, Wasz-Höckert O, 
Backman A, et al. Osteitis caused by bacille Calmette-Guérin 
vaccination: a retrospective analysis of 222 cases. J Infect Dis. 
1995;172:574–6. http://dx.doi.org/10.1093/infdis/172.2.574
  7. Moreno L, Gottrand F, Herbaux B, Savage C, Farriaux JP. Vertebral 
osteitis following BCG vaccination in a previously healthy child. 
Eur J Pediatr. 1990;149:668. http://dx.doi.org/10.1007/BF02034763
  8. Sandström S. Multifocal sclerotic BCG spondylitis in a 13-year-old 
girl. Pediatr Radiol. 1983;13:239–40. http://dx.doi.org/10.1007/
BF00973166
  9. Huang LH, Shyur SD, Weng JD. Shin-Chi, Tzen CY, Huang FY. 
Disseminated bacille Calmette-Guérin disease as the initial pre-
sentation of x-linked severe combined immunodeficiency—a case 
report. Asian Pac J Allergy Immunol. 2005;23:221–6.
Address for correspondence: Tzou-Yien Lin, Ministry of Health and 
Welfare, No. 36, Tacheng St, Datong District, Taipei 10341, Taiwan; 
email: alinpid@gmail.com
High Prevalence of Hepatitis 
Delta Virus among Persons 
Who Inject Drugs, Vietnam
Naomi Hall, Linh Nguyen Thuy, Trinh Do Thi Diem, 
Allison Waters, Linda Dunford, Jeff Connell, 
Michael Carr, William Hall, Lan Anh Nguyen Thi
Author affiliations: National Virus Reference Laboratory,  
University College Dublin, Dublin, Ireland (N. Hall, A. Waters,  
L. Dunford, J. Connell, M. Carr, W. Hall); Laboratory for  
Molecular Diagnostics, National Institute of Hygiene and  
Epidemiology, Ha Noi, Vietnam (L.N. Thuy, T.D.T. Diem,  
L.A.N. Thi)
DOI: http://dx.doi.org/10.3201/eid2103.141147
540 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 21, No. 3, March 2015
LETTERS
To the Editor: Hepatitis delta virus (HDV) is a small 
RNA virus that infects and persists only in persons whose 
samples test positive for hepatitis B surface antigen (HB-
sAg) (1). Phylogenetic analysis has revealed 8 HDV geno-
types (2) with evidence of distinct global geographic distri-
butions and pathogenicity (3,4). The implications of HDV 
infection in Vietnam have been unclear. Studies of persons 
who have chronic illness caused by HBV in populations 
of southern and northern Vietnam reported no cases or 
low prevalence (1.3%), respectively (5,6). In contrast, our 
multicenter study of chronically HBV-infected persons in 
2009 showed a higher overall HDV seroprevalence rate of 
10.7% (34/318) (7). These rates varied among regions of 
Vietnam and groups that had varying risk factors for infec-
tion. Higher rates were observed among persons who inject 
drugs (PWIDs) (20/78, 25.6%), commercial sex workers 
(5/57, 8.8%), and military recruits (8/45, 17.8%). A 2013 
study, in which PCR-based methods were used, reported 
a high rate of HDV RNA detection (41/266, 15.4%) in a 
cohort of HBV-infected persons in the city of Ha Noi (also 
known as Hanoi) collected during 2000–2009 (8). Illnesses 
of these patients ranged from acute hepatitis to severe liver 
disease, but injection of drugs was not reported. To better 
clarify the prevalence of HDV, we conducted serologic and 
molecular testing focusing on PWIDs from different geo-
graphic regions of Vietnam.
During 2010–2011, we screened consecutive samples 
(n = 1,999) from PWIDs from 5 centers (Ha Noi and Hai 
Phong in northern, Da Nang and Khanh Hoa in central, and 
Can Tho in southern Vietnam) for HBsAg. In each center, we 
recruited PWIDs to obtain 200 participants per year follow-
ing national guidelines for annual sentinel surveillance of 
HIV (http://www.vaac.gov.vn/Download.aspx/C64DBE4B-
B9074A489283056ACF639780/1/Huong_dan_giam_sat_
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Figure. Maximum-likelihood phylogenetic tree of hepatitis delta virus (HDV) genotypes 1 and 2 from Vietnam. A 472-nt fragment 
(corresponding to nucleotides 802–1,273 from HDV isolate C15; Genbank accession no. KF660600) was used to construct the 
phylogram. HDV genotyping was done by using amplification and bidirectional sequencing of the R0 region as described by Le Gal et 
al. (2). Bootstrap resampling was done for 1,000 replicates of the dataset using the neighbor-joining algorithm; values >70% are shown 
at the nodes. Bold text indicates samples from patients in Vietnam; location, year, and risk group are indicated. Genbank accession 
numbers are shown in parentheses. Scale indicates substitutions per position. PWID, person who injects drugs; SW, sex worker.
trong_diem_2010.doc). Ethical approval for the study was 
obtained from the National Institute of Hygiene and Epi-
demiology in Ha Noi. Samples collected from 300 (15%) 
persons were HBsAg positive, consistent with our previous 
study (7). Of these, 294 were subsequently screened by using 
ELISA for anti-HDV IgG; reactive samples were tested for 
HDV IgM. HDV IgG was detected in 45/294 (15.3%) sam-
ples; 20 were also HDV IgM positive (6.8% total; 44.4% of 
IgG-positive samples). Serologic analysis revealed consider-
able differences in prevalence by geographic region. HDV 
seroprevalence rates were high among PWIDs from north-
ern Vietnam (30.2% and 29.4% in Ha Noi and Hai Phong, 
respectively), but a lower seroprevalence rate was observed 
in Da Nang (5.3%), and intermediate rates were found in 
Khanh Hoa (8.1%) and Can Tho (12.5%) in southern Viet-
nam (online Technical Appendix Tables 1, 2, http://wwwnc.
cdc.gov/EID/article/21/3/14-1147-Techapp1.pdf).
We analyzed anti-HDV–positive samples (n = 41) for 
the presence of HDV RNA using a quantitative real-time 
PCR. HDV RNA was detected in 25/41 (61%) of IgG-sero-
positive samples (median 1.2 × 104 copies/mL, range 0–1.8 × 
107 copies/mL) and 19/19 (100%) of IgM-seropositive sam-
ples (median 1.2 × 106 copies/mL, range 4.3 × 102–1.7 × 107 
copies/mL). The viral loads of HDV IgM-positive samples 
were significantly higher than those of IgM-negative samples 
(p<0.0001) (online Technical Appendix Figure 1); however, 
when only samples with detectable HDV RNA from the IgM 
negative and positive groups were analyzed, there was no sta-
tistically significant difference in viral titer (p = 0.45; online 
Technical Appendix Figure 2). Comparison of HDV RNA 
and HDV IgM seroresponses showed evidence of superin-
fection with HDV persistence in 6 cases (HDV IgM nega-
tive/RNA positive; 6/22, 27.3%; online Technical Appendix 
Figure 1). The 6 samples that were IgM negative for detect-
able RNA (median 2.9 × 105 copies/mL, range 1.1 × 103–1.8 
× 107 copies/mL) highlight the limitation of using IgM as a 
surrogate marker for HDV replication; therefore, HDV RNA 
investigation is more appropriate for IgG-positive samples.
To identify the genotypes of HDV involved, we com-
pleted nucleotide sequencing and phylogenetic analysis of 
HDV from 17 viremic patient samples from Ha Noi, Hai 
Phong, Da Nang, Khanh Hoa, and Can Tho collected from 
another study cohort during 2008–2011 (Figure) (7). Most 
(12/17, 71%) samples were HDV genotype 1 from both 
northern and southern Vietnam; 5 (29%) HDV genotype 
2 species were identified in 4 samples from Hai Phong in 
northern and 1 sample from Da Nang in central Vietnam. 
The finding that HDV-1 was the predominant genotype is 
consistent with reports by Sy et al. (19/21 HDV-1; 2/21 
HDV-2) (8), suggesting that HDV-1 is the predominant 
genotype in all parts of the country.
This study, the previous report from the National Insti-
tute of Hygiene and Epidemiology laboratory (7), and data 
from Sy et al. (8,9) indicate that HDV is highly prevalent 
in Vietnam, particularly in the northern part of the country, 
contrary to previous reports (5,6,10). In particular, our find-
ings indicate that increased efforts are needed to improve 
HBV vaccination rates among PWIDs and others with 
risk factors for infection. Over time, these interventions 
may help reduce the effects of hepatitis virus–related liver 
disease. We also intend to study HDV in other high-risk 
groups, including commercial sex workers and men who 
have sex with men.
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To the Editor: Vibrio cholerae O1, a causative agent 
of cholera, is classified into 2 biotypes, classical and El 
Tor. Since 1817, cholera has spread from the Indian sub-
continent to other regions of the globe 7 times (1). How-
ever, little information on the occurrence of cholera and V. 
cholerae in Myanmar has been published. Here, we report 
cholera cases and characterization of 58 clinical isolates 
of V. cholerae O1 serotype Ogawa recovered from pa-
tients with diarrhea in Yangon, Myanmar, during Febru-
ary 2012–June 2013.
During February and August 2012, rectal swab 
specimens were collected from patients suspected of 
having cholera in 4 hospitals in Yangon: New Yangon 
General Hospital, North Okkalapa General Hospital, 
Thingangyun Sanpya General Hospital, and Yangon Chil-
dren Hospital. The specimens were cultured on thiosulfate 
citrate bile salts sucrose agar plates. After overnight incu-
bation, several colonies that resembled to those of V. chol-
erae were confirmed as serogroup O1 by using slide ag-
glutination tests with specific monoclonal antibodies (2).
Of the tested specimens, 34 isolates carried the tcpA 
gene, encoding the structural subunit of toxin-coregulated 
pilus, and the rstR gene, the repressor gene in the chol-
era toxin encoding (CTX) phage (3); these results may 
indicate that these strains belonged to the El Tor biotype. 
However, identification of the sequence type of the chol-
era toxin B subunit gene in these isolates revealed that 
they were of classical type (ctxBCla). Thus, these isolates 
were classified as atypical El Tor V. cholerae O1 (4) 
carrying ctxBCla and rstREl. Currently, the predominant 
clones causing cholera in Asia and Africa are atypical 
El Tor V. cholerae, CIRS101, and CIRS101-like vari-
ants (5,6). Myanmar isolates from 2012 and the CIRS101 
strain contained a single nucleotide polymorphism in the 
tcpA gene at nt 266 (A→G) of the prototype seventh pan-
demic El Tor (N16961) strain.
Pulsed-field gel electrophoresis (PFGE) (7) using the 
2012 isolates revealed 9 patterns (Table, http://wwwnc.
cdc.gov/EID/article/21/3/14-1309-T1.htm). During the 
initial phase of cholera occurrences, V. cholerae O1 was 
mainly isolated from adults, and 9 pulsotypes were ob-
served. During the later period (May–August), most iso-
lates were from children <5 years of age, and pulsotype 
Y6 predominated.
We carried out multilocus variable-number tandem-
repeat analysis (MLVA) (8) of the 2012 isolates to resolve 
distinct populations. MLVA yielded 13 isolate types, and 
all 18 isolates of pulsotype Y6 exhibited either MLVA 
profile 11.6.6.17.17 or a closely related profile that dif-
fered only by 1 repeat number. These data suggest that 
cholera was contracted mainly in adults and was caused 
by multiclonal V. cholerae O1. However, in children, V. 
cholerae has transformed from single clonal expansion 
since May 2012.
During March–June 2013, we extended our studies 
to characterize cholera organisms isolated from patients 
with severe diarrhea who were admitted to the original 4 
hospitals as well as 2 additional hospitals, Yankin Chil-
dren Hospital and Insein General Hospital. Of 24 cases, 
16 patients showed symptoms of severe dehydration, in-
cluding 1 patient who experienced shock. Other common 
symptoms in this patient population included fever (50%, 
12/24), vomiting (92%, 22/24), and abdominal pain (33%, 
8/24). Although fever is less common among patients with 
cholera-associated diarrhea (9), the frequency of fever was 
considerably high in this study. PFGE reveled 23 of the 24 
isolates were identical to pulsotype Y7, which was the sec-
ond-most prevalent pattern in 2012; MLVA profiles were 
also similar to those from 2012. Thus, the occurrences of 
cholera in 2013 may have been related to persistent trans-
mission of a clone from 2012.
According to surveillance records from the Yangon Re-
gional Health Center, the reported number of diarrhea cases 
in Yangon increased from 11,651 in 2010 and 11,016 in 2011 
to 15,540 in 2012 and 13,919 in 2013. Although there were 
no reports of cholera outbreaks in Yangon, PFGE/MLVA re-
sults revealed that most of the cholera cases in this study 
were caused by isolates belonging to identical or closely re-
lated types. Thus, cholera outbreaks could have occurred in 
Yangon, and the related clone may have persisted.
In Myanmar, the illness rate for severe diarrhea is esti-
mated to be 2.6–3.5 per 100,000 persons and the mortality 
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